Financials

News Ideas Discussions Technicals Forecast Seasonals Bonds

HIK/N fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to HIKMA PHARMACEUTICALS operating, investing, and financing activities

HIK/N free cash flow for H2 24 is 4.57 B MXN. For 2024, HIK/N free cash flow was 6.59 B MXN and operating cash flow was 9.96 B MXN.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: MXN

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—